Long non-coding RNAs (lncRNAs) play a significant role in tumor biology, influencing key cancer hallmarks. Recent advances in sequencing technologies have revealed that up to 70% of the human genome is transcribed into non-coding RNA, with lncRNAs being a major component. These lncRNAs are involved in various cellular processes, including gene regulation, chromatin modification, and transcriptional control. They are deregulated in many cancers and show tissue-specific expression, contributing to tumor progression. The hallmarks of cancer include sustaining proliferative signaling, evading growth suppressors, enabling replicative immortality, activating invasion and metastasis, inducing angiogenesis, and resisting cell death. LncRNAs are involved in these processes. For example, they can regulate cell proliferation by modulating signaling pathways, such as through the steroid receptor RNA activator (SRA) and the long ncRNA PCAT-1. LncRNAs also play a role in evading growth suppressors by interacting with tumor suppressor genes, such as ANRIL, which represses the expression of tumor suppressor genes like p15(INK4B). In enabling replicative immortality, lncRNAs like TERC and TERRA are involved in telomere regulation, which is crucial for unlimited cell division. TERC is a component of telomerase, an enzyme that maintains telomere length, while TERRA regulates telomerase activity. LncRNAs also contribute to activating invasion and metastasis by promoting cell motility and altering gene expression, as seen with MALAT1 and HOTAIR. These lncRNAs can influence the expression of genes involved in cell migration and metastasis. Inducing angiogenesis is another hallmark where lncRNAs play a role. For instance, αHIF, a natural antisense transcript, regulates HIF1α, a key regulator of angiogenesis. Additionally, sONE, an antisense RNA, regulates eNOS, which is involved in angiogenesis. These examples highlight the diverse functions of lncRNAs in cancer development and progression. Overall, lncRNAs are emerging as important regulators in cancer biology, influencing various hallmarks of cancer. Their roles in gene regulation, chromatin modification, and signaling pathways make them potential targets for new therapeutic strategies. Further research is needed to fully understand the mechanisms by which lncRNAs contribute to cancer and to develop targeted therapies based on their functions.Long non-coding RNAs (lncRNAs) play a significant role in tumor biology, influencing key cancer hallmarks. Recent advances in sequencing technologies have revealed that up to 70% of the human genome is transcribed into non-coding RNA, with lncRNAs being a major component. These lncRNAs are involved in various cellular processes, including gene regulation, chromatin modification, and transcriptional control. They are deregulated in many cancers and show tissue-specific expression, contributing to tumor progression. The hallmarks of cancer include sustaining proliferative signaling, evading growth suppressors, enabling replicative immortality, activating invasion and metastasis, inducing angiogenesis, and resisting cell death. LncRNAs are involved in these processes. For example, they can regulate cell proliferation by modulating signaling pathways, such as through the steroid receptor RNA activator (SRA) and the long ncRNA PCAT-1. LncRNAs also play a role in evading growth suppressors by interacting with tumor suppressor genes, such as ANRIL, which represses the expression of tumor suppressor genes like p15(INK4B). In enabling replicative immortality, lncRNAs like TERC and TERRA are involved in telomere regulation, which is crucial for unlimited cell division. TERC is a component of telomerase, an enzyme that maintains telomere length, while TERRA regulates telomerase activity. LncRNAs also contribute to activating invasion and metastasis by promoting cell motility and altering gene expression, as seen with MALAT1 and HOTAIR. These lncRNAs can influence the expression of genes involved in cell migration and metastasis. Inducing angiogenesis is another hallmark where lncRNAs play a role. For instance, αHIF, a natural antisense transcript, regulates HIF1α, a key regulator of angiogenesis. Additionally, sONE, an antisense RNA, regulates eNOS, which is involved in angiogenesis. These examples highlight the diverse functions of lncRNAs in cancer development and progression. Overall, lncRNAs are emerging as important regulators in cancer biology, influencing various hallmarks of cancer. Their roles in gene regulation, chromatin modification, and signaling pathways make them potential targets for new therapeutic strategies. Further research is needed to fully understand the mechanisms by which lncRNAs contribute to cancer and to develop targeted therapies based on their functions.